Showing results (31-40 of 68) with videos related to
Sort By:
Pageof 7
JAMA Network Open|May 16, 2023
Patterns of Manufacturer Coupon Use for Prescription Drugs in the US, 2017-2019So-Yeon Kang, Angela Liu, Gerard Anderson, et al.BMJ Open|June 14, 2020
Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015-2017: a cross-sectional studyThomas J Moore, James Heyward, Gerard Anderson, et al.Journal of Managed Care & Specialty Pharmacy|April 27, 2026
Medicaid access to Most Favored Nation through the Pfizer agreement: The unanswered issuesJeromie Ballreich, Joseph Levy, Tucker Desmond, et al.Health Affairs Scholar|October 16, 2024
Biopharmaceutical pipeline funded by venture capital firms, 2014 to 2024So-Yeon Kang, Mingqian Liu, Jeromie Ballreich, et al.Medical Care Research and Review : MCRR|August 18, 2023
Do Insurers With Greater Market Power Negotiate Consistently Lower Prices for Hospital Care? Evidence From Hospital Price Transparency DataYang Wang, Mark K Meiselbach, Jianhui Xu, et al.Journal of Managed Care & Specialty Pharmacy|December 24, 2021
Coverage of genetic therapies for spinal muscular atrophy across fee-for-service Medicaid programsJeromie Ballreich, Ijeamaka Ezebilo, Banda Abdallah Khalifa, et al.The Journal of Ambulatory Care Management|August 27, 2019
The Common Attributes of Successful Care Manager Programs for High-Need, High-Cost Persons: A Cross-Case AnalysisEmilia G Thurber, Cynthia Boyd, Bruce Leff, et al.Journal of Managed Care & Specialty Pharmacy|December 28, 2023
Filgrastim and infliximab biosimilar uptake in Medicare Advantage compared with Traditional Medicare, 2016-2019Angela Liu, Andrew Xuan, Mariana Socal, et al.JAMA Ophthalmology|July 28, 2022
Association Between Open Payments-Reported Industry Transfers of Value and Prostaglandin Analog Prescribing in the USAndrew M Nguyen, Kelly E Anderson, Gerard Anderson, et al.Journal of Pharmaceutical Policy and Practice|October 14, 2017
Branded prescription drug spending: a framework to evaluate policy optionsJeromie Ballreich, G Caleb Alexander, Mariana Socal, et al.Pageof 7